Banks
-
Regulators’ supportive words have saved AT1, but prices are prohibitively high -
With cases expected on four fronts, the technicalities of Swiss banking law will be publicly aired over the coming years and months
-
UnitedHealth brings jumbo deal but banks stay on the sidelines
-
Overlap between banks is tempting to rivals, as UBS works out new strategy
-
More companies are considering selling new shares or convertibles to ride out the volatility and the impact of rate hikes on balance sheets
-
The shotgun rescue of Credit Suisse poses a dilemma for UBS in corporate finance — should it carry on with the restructuring plan or try to regain its former swagger?
-
Rights issue volumes have surged in Europe this week as bankers expect more activity
-
First deal since Credit Suisse debacle gets bulging books for both tranches
-
CS staffers keep an eye out for new jobs while waiting on merger strategy
-
The ABB was one of the few deals done in the volatile market
-
Premiums are six times higher than those expected before Credit Suisse's sudden collapse
-
Swiss bank is looking to sooth bond investors’ anxiety and concerns following its take over of Credit Suisse
